Deep Dive digital magazine

pharmaphorum’s digital magazine Deep Dive is published in online and pdf versions six times a year and reaches a global audience of highly engaged pharmaceutical and biotechnology decision-makers.

Each Deep Dive issue combines a focus topic – either sales and marketing, digital, market access, oncology, patients or R&D – with an additional mixture of thought-provoking content and commercial opportunities include:

 Features (interview style article, up to 2,000 words)
 Features (client-written article, up to 2,000 words)
 12 questions with...
 Case studies
 Company profiles
 Digital advertising
 Edition sponsorship
 Bespoke editions

The Deep Dive team can offer full editorial support in planning and writing articles, including the inclusion of appropriate graphics and links. Articles receive a one-month cycle of promotion and a digital and print PDF versions of articles are provided after the issue is published.

In 2023, the companies that benefitted from this included: Alexion, AstraZeneca, Beigene, Daiichi Sankyo, EVERSANA, Frontiers Health, Healthware, Lumanity, M3, NIHR, Phesi, PurpleLeaf Strategy, Real Chemistry, Research Partnership, Syneos Health, and Viseven.

Upcoming Deep Dive issues for 2024 will include:

April 2024: Market Access

Deep Dive digital magazineIn this issue: Discover why localisation is creating headaches for those working to market AMR treatments, also explore the business case for investing money, time, and resources in bringing these vital AMR drugs to patients around the world.

Additionally, ADHD medication shortages are opening the doors for unregulated 'miracle' supplements to target vulnerable patients, and with patent cliffs looming for a variety of big name therapeutics, are generics ready to take centre stage? 

Plus insights from Research Partnership and Alexion. 

Publication: w/c 22 April

 

Other upcoming topics:

 

June 2024: Oncology
  • Top stories and trends from ASCO
  • Treating the patient and the person

Plus:

  • Palliative care and integrative therapies
  • A history of leukemia treatment 
 
September 2024: Sales & Marketing
  • Passionate not patronising: Why the words we use matter
  • The role of local partnerships in global pharma marketing

Plus:

  • Balancing trust and innovation with AI images 
  • Creating personalised messaging in a diverse world

 

October 2024: Patients & Partnerships
  • Hop on board: Bringing clinical research to the people 
  • Navigating data privacy and security concerns in patient-centric initiatives

Plus:

  • Leveraging digital health platforms for patient communities 
  • Transforming passive patients into active partners
 
November 2024: Digital Health
  • Insights and updates from Frontiers Health 2024 
  • Has AI lived up to the hype?

Plus:

  • Using technology to identify RNA drug targets
  • Is it time to start talking about AI sustainability?

Let us help you connect with your clients, email advertising@pharmaphorum.com or download our media pack for more information about Deep Dive and our other offerings.